Tiotropium and Salmeterol PK Study in COPD Patients
NCT00673478
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
Tiotropium+Salmeterol
DRUG:
Salmeterol
DRUG:
Tiotropium
Sponsor
Boehringer Ingelheim